NewAmsterdam Pharma Company N.V.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & Equivalents | $490.0M | $771.7M | $340.5M | — |
| Accounts Receivable | — | — | — | — |
| Inventory | — | — | — | — |
| Total Current Assets | $675.7M | $863.4M | $346.8M | $478.0M |
| Property, Plant & Equipment | $383.0K | $242.0K | $46.0K | $34.0K |
| Goodwill | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — |
| Total Assets | $769.3M | $864.6M | $347.1M | $478.5M |
| Liabilities | ||||
| Accounts Payable | $9.0M | $4.7M | $16.9M | $11.9M |
| Total Current Liabilities | $85.8M | $106.9M | $49.9M | $36.1M |
| Long-Term Debt | — | — | — | — |
| Total Liabilities | $85.9M | $107.1M | $58.7M | $48.4M |
| Stockholders' Equity | ||||
| Retained Earnings | $-762.4M | $-558.6M | $-317.0M | $-140.0M |
| Total Stockholders' Equity | $683.4M | $757.5M | $288.4M | $430.1M |